Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: "in explicit technical detail"

than if you think not why we have 11,6mio from pds in the last 10Q

with only 7 mickey mouse license

8,5mio to much in the bank before tax

if we lost realy the ARS, what i not think, we can 100% taxable this lost so we pay nothing only time !!!

i say the next 10Q

show last 7 license minimum 10mio if all pay one time

+

12mio. if the J3 pay monthly what i think

22mio. in the next 10Q

goerner say also an aquisation with litle money from the bank DEB finacing what bank give a OTC Company money with not clear revenues stream / net income stream!!!!!!!!!!!!!!!!!!!!!!!!!!!!

this is 100% what you can take from goerner

The criteria we have outlined for M&A will target revenue-producing companies at, or near, operating profitability in niche, growth markets. I expect that we will use a combination of cash, equity, and less likely debt to accomplish these objectives.

1.

if we want buy any company like this we need a much better share price first minimum 1.50$$$$$$$$$$ a share so we will have 170mio left only in shares

2.

two good 10Q more than 10mio net income + 20mio

3.

the money from J3 for the settlement 100mio.

all in all 300mio maybe we buy a company 50/50 with TPL over PDS

than we have 600mio left without money from any bank

Share
New Message
Please login to post a reply